Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2000

View Archived Issues

Prana to adapt Alzheimer's therapy for use in Creutzfeldt-Jakob disease

Tripedia receives FDA approval for use in the entire DTP immunization series

Licensing opportunity from NIH: cloned hepatitis C virus genome

Licensing opportunity from NIH: HCV and bovine viral diarrhea virus chimeric genomes

Corixa overviews key developments

SignalGene to acquire Nova Molecular

Phase I PentaLyte clinical trial successfully completed

ERS congress presentations describe efficacy and safety of roflumilast

Recent clinical results support use of alpha1-blockers in secondary pulmonary hypertension

Selective ETA receptor antagonist LBL-031 inhibits ET-1- and LPS-induced microvascular leakage

Schering-Plough presents newly discovered selective M2 antagonists at ACS

Factor Xa inhibitors with anticoagulant and antithrombotic effects identified at Lilly

Bicyclic heteroarylethanolamine-containing compounds as potent and selective beta3-AR agonists

Cytogen and Advanced Magnetics terminate merger, enter marketing agreement

ACS news: 3-D presents recently designed iodinated thrombin inhibitors

Novel N-hydroxyformamide inhibitor of TACE and TNF production: GW-4459

Topiramate has beneficial effects in transformed migraine

New formulation of Pfizer's Zeldox approved in Sweden; launch imminent

New use for topiramate: bulimia nervosa Rx

Anticonvulsants for cluster headache

U. of Michigan team discovers non-nucleoside antivirals

Peptide immunomodulating compounds reported in patent by Cytran

Potential therapeutic agents for pain identified by AstraZeneca

Bayer investigates inhibition of raf kinase signaling pathway as new approach to cancer

Substituted imidazoles as H3 receptor antagonists emerge from joint research program

Bayer claims nonsteroidal progesterone receptor modulators and their use

Schering-Plough seeks FDA approval of desloratadine for chronic idiopathic urticaria

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.